New Board Appointments
Retina Australia directors are thrilled to announce the recent appointment of Associate Professor Anai Gonzelez-Cordero and Dr Alexis (Ceecee) Britten-Jones to the Board. Anai and Ceecee have been long...
First treatment for geographic atrophy approved in Australia
Apellis' SYFOVRE® (pegcetacoplan) TGA Approved Apellis Pharmaceuticals, Inc. announced today that Australia’s Therapeutic Goods Administration...
2025 Research Grants awarded
Retina Australia is delighted to announce two new Research Grants awarded for 2025. Both grant projects will be focusing on the discovery of potential new...
Top 10 Research Priorities for Inherited Retinal Disease
We are thrilled to share the Top 10 Research Priorities for Inherited Retinal Disease,...
Launch of the Geographic Atrophy Case for Action Report
The Parliamentary Friends for Eye Health and Vision Care The Geographic Atrophy Case for Action...
$4M MRFF Grant awarded for National Platform for Therapeutic mRNA Development
The Australian Government's Medical Research Future Fund (MRFF) has...
$1.5M NHMRC Partnership grant awarded to genetic blindness study
A $1.5M National Health and Medical Research Council (NHMRC) Partnership Grant has been awarded...
2024 Research Grants Announced
Retina Australia is delighted to announce two new Research Grant recipients for 2024. The new projects will focus on Stargardt disease and Virtual Reality...
Retina Australia’s website upgraded, rebranded and accessibility compliant
Retina's Australia's new website is now live, upgraded for...
2023 Research Grants Announced
Retina Australia is delighted to announce the Research Grant Recipients for 2023. This year, Retina Australia has provided over $115,000 in funding to two...
Appointment of new CEO
Retina Australia is thrilled to announce that Julia Hall has been appointed as the inaugural Chief Executive Officer to lead the organisation through its next phase of development. Julia...
Queen’s Birthday Honours for Leighton and Rosemary Boyd
We are delighted to announce that our Chairman Leighton Boyd, and Company Secretary Rosemary...
Do it in the Dark™ 2022 Fundraiser Launch
Do it in the Dark™ is back this March & April. Now in its second year, Do it in...
Retina Australia 2022 Research Grant Recipients Announced
We are pleased to announce that the 2022 recipients of the Retina Australia medical...
World Retina Day 2021
World Retina Day is taking place on September 25th, 2021. This year, Retina International is highlighting the impact of the COVID-19 Pandemic on the inclusion and wellbeing of its global...
Annual General Meeting 2021
Notice is hereby given that the 37th Annual General Meeting of Retina Australia will be held on Saturday 9th October via Zoom at 1.30pm...
Free webinar series
The next webinar in our free series will take place on Saturday 9th October at 2pm (AEST). The topic is Clinical genetics services helping with genetic information, counselling and access...
Our inaugural Giving Day
We are excited to announce our Inaugural Giving Day which will launch on Monday, 21 June 2021 at 10:00 am AEST. This Giving Day, help us empower over 15,000 Australians...
Retina Australia 2021 Grant Recipients Announced
We are pleased to announce that the 2021 recipients of the Retina Australia medical research grants are Dr Lauren...
Webinar Event: Gene therapy, clinical trials and new developments in IRD research
The regulatory approval and commercialisation of Luxturna in 2017...